knowledge -WSS

knowledge

author：focus 2025-09-30 04:43:08 Page View：59

Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to invest in privately held startups.

The bank announced Wednesday that it has closed its first-ever life sciences fund, called West Street Life Sciences I. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

First-time funds have been difficult to raise during the biotech downturn. Last year, around $11.6 billion was raised by 183 new VC funds, which was the lowest fundraising total for first-timers since 2013, according to Pitchbook. Around $25.6 billion had been raised by 556 first-time funds in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What health policies could hitch a ride on a spending bill?
Next article： How to save PrEP access — and even expand it

explore

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

CVS, Rite Aid closures threaten to worsen pharmacy deserts

ScottOlson/GettyImagesPharmacieswereonceabundantintheSouthSideofChicago.Now,residentslivinginthemajo

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

FDA reorg will put new emphasis on investigations, sources say

SarahSilbiger/GettyImagesWASHINGTON—There’sabouttobeanewacronymintown.TheFoodandDrugAdministrationis

knowledge

comprehensive

explore

FDA reorg will put new emphasis on investigations, sources say